1. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms

   • Zhiqiang Zhou
   • Huicong Kang
   • Xu Zhao

   Review 26 May 2020 Pages: 2179 - 2184

2. Stroke in patients with SARS-CoV-2 infection: case series

   • Mauro Morassi
   • Daniele Bagatto
   • Alberto Vogrig

   Original Communication 20 May 2020 Pages: 2185 - 2192

   

3. Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19)

   • Georgios Tsivgoulis
   • Paraskevi C. Fragkou
   • Sotirios Tsiodras

   Letter to the Editors 25 May 2020 Pages: 2193 - 2195

   

4. Acute transverse myelitis after COVID-19 pneumonia

   • Maike Munz
   • Swen Wessendorf
   • Matthias Reinhard

   Letter to the Editors 26 May 2020 Pages: 2196 - 2197

   

5. Hereditary neuropathy with liability to pressure palsies

   • Shahram Attarian
   • Farzad Fatehi
   • Davide Pareyson

   Review 15 April 2019 Pages: 2198 - 2206

   

6. Is Parkinson’s disease a chronic low-grade inflammatory bowel disease?

   • Malvyne Rolli-Derkinderen
   • Laurène Leclair-Visonneau
   • Pascal Derkinderen

   Review 12 April 2019 Pages: 2207 - 2213

   

7. Disease activity outcomes with different washout periods after switching from natalizumab to an alternative disease-modifying therapy

   • Le H. Hua
   • Haleigh Harris
   • Carrie M. Hersh

   Original Communication 09 April 2020 Pages: 2214 - 2220

   

8. Cortical myoclonus and epilepsy in a family with a new SLC20A2 mutation

   • Antonietta Coppola
   • Laura Hernandez-Hernandez
   • Sanjay M. Sisodiya

   Original Communication Open access 09 April 2020 Pages: 2221 - 2227

   

9. Metabolomic changes associated with frontotemporal lobar degeneration syndromes

   • Alexander G. Murley
   • P. Simon Jones
   • James B. Rowe

   Original Communication Open access 10 April 2020 Pages: 2228 - 2238

   

10. Parkinsonism as a late presentation of lymphomatosis cerebri following high-dose chemotherapy with autologous stem cell transplantation for primary central nervous system lymphoma

    • Sarah Merrill
    • David J. Mauler
    • Maciej M. Mrugala

    Original Communication 15 April 2020 Pages: 2239 - 2244

    

11. Longitudinal serum neurofilament light chain (sNfL) concentration relates to cognitive function in multiple sclerosis patients

    • Flavia Mattioli
    • F. Bellomi
    • R. Capra

    Original Communication 15 April 2020 Pages: 2245 - 2251

    

12. Etiologic distribution of dizziness and vertigo in a referral-based dizziness clinic in South Korea

    • Hyo-Jung Kim
    • Ja-Ok Lee
    • Ji-Soo Kim

    Original Communication 16 April 2020 Pages: 2252 - 2259

    

13. Visually-induced dizziness is associated with sensitivity and avoidance across all senses

    • Georgina Powell
    • Hannah Derry-Sumner
    • Petroc Sumner

    Original Communication Open access 18 April 2020 Pages: 2260 - 2271

    

14. Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease

    • Yuri Matteo Falzone
    • Teuta Domi
    • Nilo Riva

    Original Communication 18 April 2020 Pages: 2272 - 2280

    

15. Spatial and egocentric mental rotation in patients with cervical dystonia

    • Massimiliano Conson
    • Gabriella Santangelo
    • Marcello Esposito

    Original Communication 19 April 2020 Pages: 2281 - 2287

    

16. Contributions to the study of spinocerebellar ataxia type 38 (SCA38)

    • José Gazulla
    • Elvira Orduna-Hospital
    • José Berciano

    Original Communication 20 April 2020 Pages: 2288 - 2295

    

17. Imaging dopamine function and microglia in asymptomatic LRRK2 mutation carriers

    • Morten Gersel Stokholm
    • Alicia Garrido
    • Nicola Pavese

    Original Communication Open access 21 April 2020 Pages: 2296 - 2300

    

18. Moyamoya angiopathy: radiological follow-up findings in Finnish patients

    • Marika Savolainen
    • Johanna Pekkola
    • Turgut Tatlisumak

    Original Communication Open access 22 April 2020 Pages: 2301 - 2306

    

19. Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy

    • Christina Engl
    • Laura Tiemann
    • Mark Mühlau

    Original Communication Open access 23 April 2020 Pages: 2307 - 2318

    

20. Light therapy for multiple sclerosis-associated fatigue: a randomized, controlled phase II trial

    • Farrah J. Mateen
    • Andre C. Vogel
    • Aleksandar Videnovic

    Original Communication 24 April 2020 Pages: 2319 - 2327

    

21. Predicting onset of secondary-progressive multiple sclerosis using genetic and non-genetic factors

    • Elina Misicka
    • Corriene Sept
    • Farren B. S. Briggs

    Original Communication 24 April 2020 Pages: 2328 - 2339

    

22. Utriculo-ocular pathway dysfunction is more frequent in vestibular migraine than probable vestibular migraine

    • Chisato Fujimoto
    • Teru Kamogashira
    • Shinichi Iwasaki

    Original Communication 24 April 2020 Pages: 2340 - 2346

23. Bilateral posterior semicircular canal dysfunction: a new finding with video head impulse test

    • Florencia Lerchundi
    • Alfredo Hernan Laffue
    • Francisco Jose Gualtieri

    Original Communication 28 April 2020 Pages: 2347 - 2352

    

24. Sustained response to subcutaneous immunoglobulins in chronic ataxic neuropathy with anti-disialosyl IgM antibodies (CANDA): report of two cases and review of the literature

    • D. Marastoni
    • L. Africa
    • F. Giannini

    Original Communication 28 April 2020 Pages: 2353 - 2361

    

25. Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population

    • Julia Sabin
    • Sarai Urtiaga
    • DMF Study Group

    Original Communication 29 April 2020 Pages: 2362 - 2371

    

26. Neural mechanisms underlying state mental fatigue in multiple sclerosis: a pilot study

    • Michelle H. Chen
    • Glenn R. Wylie
    • Helen M. Genova

    Original Communication 29 April 2020 Pages: 2372 - 2382

    

27. Effects of perceptible and imperceptible galvanic vestibular stimulation on the postural control of patients with bilateral vestibulopathy

    • Andreas Sprenger
    • Peer Spliethoff
    • Christoph Helmchen

    Original Communication 30 April 2020 Pages: 2383 - 2397

    

28. Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy

    • Alma Osmanovic
    • Gresa Ranxha
    • Olivia Schreiber-Katz

    Original Communication Open access 02 May 2020 Pages: 2398 - 2407

    

29. Whole-body muscle MRI of patients with MATR3-associated distal myopathy reveals a distinct pattern of muscular involvement and highlights the value of whole-body examination

    • Alexander Mensch
    • Torsten Kraya
    • Stephan Zierz

    Original Communication Open access 02 May 2020 Pages: 2408 - 2420

    

30. The IN-DEEP project “INtegrating and Deriving Evidence, Experiences, Preferences”: a web information model on magnetic resonance imaging for people with multiple sclerosis

    • Cinzia Colombo
    • Paolo Confalonieri
    • Graziella Filippini

    Original Communication 02 May 2020 Pages: 2421 - 2431

    

31. Characteristic muscle signatures assessed by quantitative MRI in patients with Bethlem myopathy

    • Ruth Salim
    • Julia Rebecka Dahlqvist
    • John Vissing

    Original Communication 03 May 2020 Pages: 2432 - 2442

    

32. Longitudinal medication profile and cost savings in Parkinson’s disease patients after bilateral subthalamic nucleus deep brain stimulation

    • Jing Han Ng
    • Angela An Qi See
    • Nicolas Kon Kam King

    Original Communication 04 May 2020 Pages: 2443 - 2454

    

33. Familial Creutzfeldt–Jakob disease homozygous to the E200K mutation: clinical characteristics and disease course

    • Zeev Nitsan
    • Oren S. Cohen
    • Ron Milo

    Original Communication 04 May 2020 Pages: 2455 - 2458

34. Riluzole prescribing, uptake and treatment discontinuation in people with amyotrophic lateral sclerosis in Scotland

    • Kiran Jayaprakash
    • Stella A. Glasmacher
    • the CARE-MND Consortium

    Letter to the Editors Open access 23 May 2020 Pages: 2459 - 2461

    

35. Refractory anti-NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review

    • Serena Marita Lazzarin
    • Marco Vabanesi
    • Fabio Minicucci

    Short Commentary 13 June 2020 Pages: 2462 - 2468

    

36. The changing face of neurosurgery for the older person

    • Ellie Edlmann
    • Peter C. Whitfield

    Neurological Update 25 April 2020 Pages: 2469 - 2474

37. Biomarkers in the diagnosis and prognosis of Alzheimer’s disease

    • N. Davda
    • R. Corkill

    Journal club 07 July 2020 Pages: 2475 - 2477

38. Wiktor Stein (1899–1979)

    • Jarosław Sak
    • Antoni Niedzielski

    Pioneers in Neurology Open access 17 July 2019 Pages: 2478 - 2479

    

39. Correction to: Intracerebral haemorrhage on the acute stroke unit

    • M. D. Edwards
    • T. A. T. Hughes

    Correction 28 April 2020 Pages: 2480 - 2480

40. Correction to: Endovascular stroke treatment’s impact on malignant type of edema (ESTIMATE)

    • Hannah Fuhrer
    • Silvia Schönenberger
    • For the IGNITE-study group

    Correction 06 May 2020 Pages: 2481 - 2481

41. Correction to: Caregiver burden and its related factors in advanced Parkinson’s disease: data from the PREDICT study

    • Alessandro Tessitore
    • Pietro Marano
    • Angelo Antonini

    Correction Open access 20 May 2020 Pages: 2482 - 2483

    

42. Correction to: Optical coherence tomography shows neuroretinal thinning in myelopathy of adrenoleukodystrophy

    • Wouter J. C. van Ballegoij
    • Sander C. Kuijpers
    • Frank D. Verbraak

    Correction Open access 20 May 2020 Pages: 2484 - 2484